Groundbreaking Treatment: Elevidys Expands Access for Duchenne Patients
The U.S. Food and Drug Administration (FDA) has granted traditional approval to ELEVIDYS for ambulatory Duchenne muscular dystrophyDuchenne muscular...
The U.S. Food and Drug Administration (FDA) has granted traditional approval to ELEVIDYS for ambulatory Duchenne muscular dystrophyDuchenne muscular...
A phase 3 clinical trial known as PURPOSE 1 has yielded breakthrough results in HIV prevention. The trial studied...
CellxLife, a newly established company, aims to revolutionize treatment for children with recurring metastatic Ewing sarcoma and osteosarcoma. The...
Precision BioSciences, a gene editing company, has appointed Dr. Mark Sulkowski and Dr. Jordan Feld to its Hepatitis Scientific...
Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has accepted an extension application for a new...
The FDA has approved KRAZATI (adagrasib) in combination with cetuximab as a treatment for locally advanced or metastatic colorectal...
AriBio Co., Ltd. has partnered with Kentucky Clinical Trial Laboratory (KCTL) to enhance Alzheimer’s diseaseAlzheimer’s disease testing. This collaboration...
CAPVAXIVE (V116) is an FDA-approved vaccine for adults to combat invasive pneumococcal disease (IPD). It targets the serotypes responsible...
Pyros Pharmaceuticals has received FDA approval for VIGAFYDE™, an oral vigabatrin solution for treating infantile spasms (IS) in pediatric...
PPD, a leader in clinical research, has received a CRO Leadership Award for the 13th consecutive year in recognition...